Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities

v3.24.0.1
Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets    
Tax losses carry forwards $ 682,095,000 $ 678,334,000
Inventory related 2,241,000 157,000
Intangible assets 16,990,000 11,321,000
Provision for employee related obligations 703,000 927,000
Stock-based compensation 8,803,000 10,242,000
Deferred revenue 3,742,000 1,575,000
Allowance for credit losses 119,000 66,000
Research and development credit carry forwards 20,368,000 17,658,000
Research and development capitalization (including Section 174) 19,384,000 11,454,000
Deferred Tax Assets, Equity Method Investments 1,406,000 0
Deferred tax assets (under "Other non-current assets") 5,320,000 0
Gross deferred tax assets 761,171,000 731,734,000
Valuation allowance (737,560,000) (699,694,000)
Total deferred tax assets 23,611,000 32,040,000
Deferred tax liabilities    
Intangibles assets (8,803,000) (10,988,000)
Property, plant and equipment (14,228,000) (14,652,000)
Basis difference in equity method investment 0 (8,852,000)
Other items 0 (1,903,000)
Total deferred tax liabilities (23,031,000) (36,395,000)
Net deferred tax assets (liabilities) $ 580,000 $ (4,355,000)